PR Newswire Asia's news > Biotechnology

 < Previous page   |   Detail   |   Print    Next page > 
     
Everest Medicines Enters into Letter of Intent with Hasten Biopharmaceuticals (Asia) Limited
2026-03-18T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Antengene to Present on Three Preclinical Programs at AACR 2026, Highlighting Next-Generation ADCs and AnTenGagerâ„¢ TCEs
2026-03-18T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Breakthrough at 2026 AACR! Senhwa Biosciences' CX-5461 Enters the Field of Photodynamic Therapy, Opening a New Indication Strategy
2026-03-18T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Innorna Announces FDA Clearance of IND for IN026, Advancing mRNA-based Therapies into Chronic Metabolic Diseases
2026-03-17T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Alebund Pharmaceuticals Announces Collaboration and License Agreement with R1 Therapeutics for AP306
2026-03-17T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Ribo to present ex-hepatic delivery data at RNA Leaders Europe Conference
2026-03-17T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Alphamab Oncology Announces the First Patient Dosed in a Phase I Clinical Study of PD-L1/VEGFR2 Bispecific ADC JSKN027
2026-03-17T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
BioCina Initiates Comprehensive Manufacturing Program for Patrys' Proprietary Injectable Therapeutic to Alleviate Delirium
2026-03-17T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Viva Biotech Accelerates AI-Driven Drug Discovery and Advance the 'Lab-in-the-Loop' with NVIDIA
2026-03-17T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
GenScript Biotech Corp Reports Strong FY2025 Results as Integrated Platform Strategy and Global Execution Drive High-Quality Growth
2026-03-16T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
 < Previous page    Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.